# Viking Therapeutics, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:a615e681-715b-43ed-b93f-36b5505293e7 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/viking-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 25 | | Claims under review | 1 | | Evidence records | 7 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-07T06:07:19.437306+00:00 | | Last reviewed | 2026-10-07T06:07:19.437306+00:00 | ## Identity - Legal name: Viking Therapeutics, Inc. - Display name: Viking Therapeutics, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-07T13:22:29.83064+00:00 | | Completeness | 0.409 | | Record Quality | 0.84 | | Directors | 7 | | Committees | 3 | | Governance events | 11 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Brian Lian, Ph.D.: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-01. claim_id=alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:leadership_role:5 - Charles A. Rowland, Jr: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-01. Committees: Audit Committee (member); Compensation Committee (chair). claim_id=alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:leadership_role:6 - J. Matthew Singleton: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2014-01-01. Committees: Audit Committee (chair); Compensation Committee (member). claim_id=alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:leadership_role:7 - Kathryn Rouan: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2019-01-01. claim_id=alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:leadership_role:8 - Lawson Macartney: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-01. Committees: Audit Committee (member); Compensation Committee (member); Nominating and Corporate Governance Committee (member). claim_id=alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:leadership_role:9 - Matthew W. Foehr: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2014-01-01. claim_id=alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:leadership_role:10 - Neil Aubuchon: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-01. claim_id=alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:leadership_role:11 ## Committees - Audit Committee (audit). Chair: J. Matthew Singleton. Members: J. Matthew Singleton (chair, current); Charles A. Rowland, Jr (member, current); Lawson Macartney (member, current); J. Matthew Singleton (chair, unknown); Charles A. Rowland, Jr (member, unknown); Lawson Macartney (member, unknown). committee_id=alpha:committee:viking-therapeutics-inc:audit-committee - Compensation Committee (compensation). Chair: Charles A. Rowland, Jr. Members: Charles A. Rowland, Jr (chair, current); J. Matthew Singleton (member, current); Lawson Macartney (member, current); Charles A. Rowland, Jr (chair, unknown); J. Matthew Singleton (member, unknown); Lawson Macartney (member, unknown). committee_id=alpha:committee:viking-therapeutics-inc:compensation-committee - Nominating and Corporate Governance Committee (nominating_governance). Chair: NOT_PUBLISHED. Members: Lawson Macartney (member, current); Lawson Macartney (member, unknown). committee_id=alpha:committee:viking-therapeutics-inc:nominating-and-corporate-governance-committee ## Executive leadership - Bradley T. Sheares, Ph.D.: President and Chief Executive Officer, Director [CEO]. Status: current. claim_id=alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:leadership_role:12 - Greg Zante: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:leadership_role:13 - Marianne Mancini: Chief Operating Officer [COO]. Status: current. claim_id=alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:leadership_role:14 - Neil Aubuchon: Chief Commercial Officer. Status: current. claim_id=alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:leadership_role:15 ## Governance events - DIRECTOR_APPOINTED: Brian Lian, Ph.D. seat on Viking Therapeutics, Inc., effective 2026-04-01. Effective: 2026-04-01. Detected: 2026-10-07T06:07:19.437306+00:00. event_id=alpha:event:director_appointed:1523s74 - DIRECTOR_APPOINTED: Charles A. Rowland, Jr seat on Viking Therapeutics, Inc., effective 2026-04-01. Effective: 2026-04-01. Detected: 2026-10-07T06:07:19.437306+00:00. event_id=alpha:event:director_appointed:x30z54 - DIRECTOR_APPOINTED: Lawson Macartney seat on Viking Therapeutics, Inc., effective 2026-04-01. Effective: 2026-04-01. Detected: 2026-10-07T06:07:19.437306+00:00. event_id=alpha:event:director_appointed:1fvvzw7 - DIRECTOR_APPOINTED: Neil Aubuchon seat on Viking Therapeutics, Inc., effective 2026-04-01. Effective: 2026-04-01. Detected: 2026-10-07T06:07:19.437306+00:00. event_id=alpha:event:director_appointed:f2i08z - CEO_CHANGED: Bradley T. Sheares, Ph.D. executive of Viking Therapeutics, Inc., effective 2026-04-01. Effective: 2026-04-01. Detected: 2026-10-07T06:07:19.437306+00:00. event_id=alpha:event:ceo_changed:1ypmq59 - CFO_CHANGED: Greg Zante executive of Viking Therapeutics, Inc., effective 2026-04-01. Effective: 2026-04-01. Detected: 2026-10-07T06:07:19.437306+00:00. event_id=alpha:event:cfo_changed:1om4biu - EXECUTIVE_APPOINTED: Marianne Mancini executive of Viking Therapeutics, Inc., effective 2026-04-01. Effective: 2026-04-01. Detected: 2026-10-07T06:07:19.437306+00:00. event_id=alpha:event:executive_appointed:1b4igq8 - EXECUTIVE_APPOINTED: Neil Aubuchon executive of Viking Therapeutics, Inc., effective 2026-04-01. Effective: 2026-04-01. Detected: 2026-10-07T06:07:19.437306+00:00. event_id=alpha:event:executive_appointed:5v6pyo - DIRECTOR_APPOINTED: Kathryn Rouan seat on Viking Therapeutics, Inc., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-07T06:07:19.437306+00:00. event_id=alpha:event:director_appointed:11l3cud - DIRECTOR_APPOINTED: J. Matthew Singleton seat on Viking Therapeutics, Inc., effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-07T06:07:19.437306+00:00. event_id=alpha:event:director_appointed:h41v3x - DIRECTOR_APPOINTED: Matthew W. Foehr seat on Viking Therapeutics, Inc., effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-07T06:07:19.437306+00:00. event_id=alpha:event:director_appointed:unvnyl ## Scoped resources - `alpha://company/viking-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/viking-therapeutics-inc?format=record - `alpha://company/viking-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/viking-therapeutics-inc?format=record§ion=identity - `alpha://company/viking-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/viking-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/viking-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/viking-therapeutics-inc?format=record§ion=board - `alpha://company/viking-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/viking-therapeutics-inc?format=record§ion=committees - `alpha://company/viking-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/viking-therapeutics-inc?format=record§ion=leadership - `alpha://company/viking-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/viking-therapeutics-inc?format=record§ion=ownership - `alpha://company/viking-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/viking-therapeutics-inc?format=record§ion=financials - `alpha://company/viking-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/viking-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/viking-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/viking-therapeutics-inc?format=record§ion=compensation - `alpha://company/viking-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/viking-therapeutics-inc?format=record§ion=governance - `alpha://company/viking-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/viking-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/viking-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/viking-therapeutics-inc?format=record§ion=audit - `alpha://company/viking-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/viking-therapeutics-inc?format=record§ion=legal - `alpha://company/viking-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/viking-therapeutics-inc?format=record§ion=risk - `alpha://company/viking-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/viking-therapeutics-inc?format=record§ion=cyber - `alpha://company/viking-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/viking-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/viking-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/viking-therapeutics-inc?format=record§ion=agents - `alpha://company/viking-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/viking-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/viking-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/viking-therapeutics-inc?format=record§ion=events - `alpha://company/viking-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/viking-therapeutics-inc?format=record§ion=relationships - `alpha://company/viking-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/viking-therapeutics-inc?format=record§ion=assessments - `alpha://company/viking-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/viking-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Audit Committee","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:j-matthew-singleton-vktx","name":"J. Matthew Singleton"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Audit Committee","category":"audit","role":"member","person":{"alpha_id":"alpha:person:charles-a-rowland-jr-vktx","name":"Charles A. Rowland, Jr"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Audit Committee","category":"audit","role":"member","person":{"alpha_id":"alpha:person:lawson-macartney-vktx","name":"Lawson Macartney"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Compensation Committee","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:charles-a-rowland-jr-vktx","name":"Charles A. Rowland, Jr"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Compensation Committee","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:j-matthew-singleton-vktx","name":"J. Matthew Singleton"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Compensation Committee","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:lawson-macartney-vktx","name":"Lawson Macartney"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:committee_appointment:25: `{"kind":"committee_appointment","original_name":"Nominating and Corporate Governance Committee","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:lawson-macartney-vktx","name":"Lawson Macartney"},"source_id":"governance_people_committees"}` ## Leadership - Brian Lian, Ph.D.: Director. Claim: alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:leadership_role:5. Valid from: 2026-04-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f746441482eb03c772ab5298345c23b6cf7015ca5b76ccfba7e7b2dfcac6cadc. - Charles A. Rowland, Jr: Director. Claim: alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:leadership_role:6. Valid from: 2026-04-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f746441482eb03c772ab5298345c23b6cf7015ca5b76ccfba7e7b2dfcac6cadc. - J. Matthew Singleton: Director. Claim: alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:leadership_role:7. Valid from: 2014-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f746441482eb03c772ab5298345c23b6cf7015ca5b76ccfba7e7b2dfcac6cadc. - Kathryn Rouan: Director. Claim: alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:leadership_role:8. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f746441482eb03c772ab5298345c23b6cf7015ca5b76ccfba7e7b2dfcac6cadc. - Lawson Macartney: Director. Claim: alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:leadership_role:9. Valid from: 2026-04-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f746441482eb03c772ab5298345c23b6cf7015ca5b76ccfba7e7b2dfcac6cadc. - Matthew W. Foehr: Director. Claim: alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:leadership_role:10. Valid from: 2014-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f746441482eb03c772ab5298345c23b6cf7015ca5b76ccfba7e7b2dfcac6cadc. - Neil Aubuchon: Director. Claim: alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:leadership_role:11. Valid from: 2026-04-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f746441482eb03c772ab5298345c23b6cf7015ca5b76ccfba7e7b2dfcac6cadc. - Bradley T. Sheares, Ph.D.: President and Chief Executive Officer, Director. Claim: alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:leadership_role:12. Valid from: 2026-04-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b5e6bac9cae132710fc41827a6b15381570605358a72d8ba58811c8e33d861dc. - Greg Zante: Chief Financial Officer. Claim: alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:leadership_role:13. Valid from: 2026-04-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d5ecb32844b29b219235a5863584ea8bd8883cb15aaaf287a99b0891a4bb08b0. - Marianne Mancini: Chief Operating Officer. Claim: alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:leadership_role:14. Valid from: 2026-04-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:44242be937242750583578ad04c71b6a8f0ea38e4f86dba9b117e1cf94f549f2. - Neil Aubuchon: Chief Commercial Officer. Claim: alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:leadership_role:15. Valid from: 2026-04-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6a8a982b0f2e496fd0cb91ef7840b1fdca4289185d4ea08ff5d4fafe62d5d8e3. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit Committee: Chair J. Matthew Singleton; Members J. Matthew Singleton (Chair); Charles A. Rowland, Jr; Lawson Macartney. Claim: alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:committee_record:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3542fd1310557d569b6e4ee8e82f59e1457ec5a4236184ea92aa4dd791935bfb. - Compensation Committee: Chair Charles A. Rowland, Jr; Members Charles A. Rowland, Jr (Chair); J. Matthew Singleton; Lawson Macartney. Claim: alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:committee_record:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3542fd1310557d569b6e4ee8e82f59e1457ec5a4236184ea92aa4dd791935bfb. - Nominating and Corporate Governance Committee: Chair not stated; Members Lawson Macartney. Claim: alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:committee_record:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3542fd1310557d569b6e4ee8e82f59e1457ec5a4236184ea92aa4dd791935bfb. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Viking Therapeutics, Inc.. Claim: alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:46f71055210b34435a1b378b94d0bf5e9baf969cfd1de959693d6b297514e5c0. ## Entity Status - Public listing published. Claim: alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:46f71055210b34435a1b378b94d0bf5e9baf969cfd1de959693d6b297514e5c0. ## Published Fact - US. Claim: alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:46f71055210b34435a1b378b94d0bf5e9baf969cfd1de959693d6b297514e5c0. ## Committee Appointment - J. Matthew Singleton: chair, Audit Committee. Claim: alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3542fd1310557d569b6e4ee8e82f59e1457ec5a4236184ea92aa4dd791935bfb. - Charles A. Rowland, Jr: member, Audit Committee. Claim: alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3542fd1310557d569b6e4ee8e82f59e1457ec5a4236184ea92aa4dd791935bfb. - Lawson Macartney: member, Audit Committee. Claim: alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3542fd1310557d569b6e4ee8e82f59e1457ec5a4236184ea92aa4dd791935bfb. - Charles A. Rowland, Jr: chair, Compensation Committee. Claim: alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3542fd1310557d569b6e4ee8e82f59e1457ec5a4236184ea92aa4dd791935bfb. - J. Matthew Singleton: member, Compensation Committee. Claim: alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3542fd1310557d569b6e4ee8e82f59e1457ec5a4236184ea92aa4dd791935bfb. - Lawson Macartney: member, Compensation Committee. Claim: alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3542fd1310557d569b6e4ee8e82f59e1457ec5a4236184ea92aa4dd791935bfb. - Lawson Macartney: member, Nominating and Corporate Governance Committee. Claim: alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:committee_appointment:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3542fd1310557d569b6e4ee8e82f59e1457ec5a4236184ea92aa4dd791935bfb. ## Security Listing - VKTX (NASDAQ). Claim: alpha:claim:company:a615e681-715b-43ed-b93f-36b5505293e7:security_listing:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:46f71055210b34435a1b378b94d0bf5e9baf969cfd1de959693d6b297514e5c0. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:46f71055210b34435a1b378b94d0bf5e9baf969cfd1de959693d6b297514e5c0: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/viking-therapeutics-inc). - alpha:projection-evidence:document:f746441482eb03c772ab5298345c23b6cf7015ca5b76ccfba7e7b2dfcac6cadc: [DEF 14A vktx-20260401.htm](https://www.sec.gov/Archives/edgar/data/1607678/000119312526137915/vktx-20260401.htm). - alpha:projection-evidence:document:b5e6bac9cae132710fc41827a6b15381570605358a72d8ba58811c8e33d861dc: [VKTX DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1607678/000119312526137915/vktx-20260401.htm). - alpha:projection-evidence:document:d5ecb32844b29b219235a5863584ea8bd8883cb15aaaf287a99b0891a4bb08b0: [VKTX DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1607678/000119312526137915/vktx-20260401.htm). - alpha:projection-evidence:document:44242be937242750583578ad04c71b6a8f0ea38e4f86dba9b117e1cf94f549f2: [VKTX DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1607678/000119312526137915/vktx-20260401.htm). - alpha:projection-evidence:document:6a8a982b0f2e496fd0cb91ef7840b1fdca4289185d4ea08ff5d4fafe62d5d8e3: [VKTX DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1607678/000119312526137915/vktx-20260401.htm). - alpha:projection-evidence:3542fd1310557d569b6e4ee8e82f59e1457ec5a4236184ea92aa4dd791935bfb: [Audit Committee](https://www.sec.gov/Archives/edgar/data/1607678/000119312526137915/vktx-20260401.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/viking-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/viking-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/viking-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/viking-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/viking-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-07T13:22:29.801683+00:00; recorded 2026-10-07T13:22:29.801683+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.